Centre of Excellence in Severe AsthmaCentre of Excellence in Severe Asthma
severeasthma@newcastle.edu.au
Twitter
  • Home
  • About Us
  • Our People
  • Research
    • Overview
    • Expanded Research Themes
    • List of Funded Projects
    • Publication List
    • Consumer Reference Group
    • The MASTER Study
  • News & Events
    • News
    • Upcoming Events
    • Past Events
    • Funding Opportunities
  • Tools & Resources
    • Overview
    • Clinical Resources
    • Past Webinars
    • Highlighted Publications
    • Newsletters & Annual Reports
    • Journal Club
    • Useful Links
    • For People with Severe Asthma & Their Families
    • For Healthcare Professionals
  • Contact Us
  • Severe Asthma Toolkit

Professor Peter Gibson and Associate Professor Nathan Bartlett “COVID-19 and Severe Asthma: Recommendations and looking toward treatment and prevention”

Home Professor Peter Gibson and Associate Professor Nathan Bartlett “COVID-19 and Severe Asthma: Recommendations and looking toward treatment and prevention”

“COVID-19 and Severe Asthma: Recommendations and looking toward treatment and prevention” Presented by Professor Peter Gibson and Associate Professor Nathan Bartlett

The Centre of Excellence in Severe Asthma hosted Professor Peter Gibson and Associate Professor Nathan Bartlett for a webinar on “COVID-19 and Severe Asthma: Recommendations and looking toward treatment and prevention” on 28th May 2020.

Presentation Summary:

Professor Peter Gibson introduced the “Clinical Recommendations for COVID-19 in Severe Asthma” developed by the Centre of Excellence in Severe Asthma. These recommendations are available here, and the associated infographics can be found at the severe asthma toolkit.

Key Points Covered:

  • COVID-19: The virus, transmission, symptoms and impact.
  • Severe Asthma and COVID-19, including recommendations for severe asthma management, attack management and isolation.
  • Accessing and administering monoclonal antibody therapies during the COVID-19 pandemic.
  • The safety of drugs and devices commonly used in severe asthma
  • Wellbeing during the pandemic
  • Asthma and COVID-19 risk

About Professor Peter Gibson

Professor Gibson is a world leading respiratory physician and clinical researcher. Professor Gibson works at the clinical interface as well as conducting world leading research into improving treatment regimens and management strategies for asthma and airway disease.

Associate Professor Nathan Bartlett presented on “I want my life back… Looking toward treatment and prevention of COVID-19”

Key Points Covered:

  • Anti-viral approaches to COVID-19: What to target.
    • Direct anti-viral therapies
      • Nucleoside/tide analogues
      • Viral enzyme inhibitors
    • Indirect anti-viral therapies
      • Viral receptor blockade
      • Growth factor receptors
      • Macrolide antibiotics
      • Hydroxychloroquine
      • Toll-like receptors and TLR2 agonist
  • Effective drug delivery
    • Polymer Lipid Hybrid Nano-particles
  • Vaccinations – long term goal for wide spread prevention

About Associate Professor Nathan Bartlett

Associate Professor Bartlett is the head of the Viral Immunology and Respiratory Disease group and is based at the Hunter Medical Research Institute. Associate Professor Bartlett is currently exploring novel therapies and treatments to fight COVID-19. His team is exploring a range of anti-viral options for this virus, partnering with other researchers to explore different methods to fight the virus.

To view other webinars on Severe Asthma please click here

News

Clinical Recommendations for COVID-19 in Severe Asthma
Clinical Recommendations for COVID-19 in Severe Asthma

May 15th, 2020

Read More
CANCELLED: CRE Severe Asthma Webinar: "Exercise-induced Laryngeal Obstruction (EILO). What is it, who gets it, how you assess it, what you do about it?"
CANCELLED: CRE Severe Asthma Webinar: "Exercise-induced Laryngeal Obstruction (EILO). What is it, who gets it, how you assess it, what you do about it?"

March 13th, 2020

Read More
POSTPONED: Laryngeal Dysfunction Workshop
POSTPONED: Laryngeal Dysfunction Workshop

March 13th, 2020

Read More

Join Our Mailing List

Funded By

Twitter Feed

Tweets by SevereAsthmaCRE

Contact us

Postal Address
NHMRC Centre of Excellence in Severe Asthma
c/o Hunter Medical Research Institute
Locked Bag 1000
New Lambton, NSW 2305
AUSTRALIA
Email
Twitter
  • Website Terms of Use
Copyright 2016    CRICOS Provider Number 00109J    The University of Newcastle, Australia